Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and “functional” haemoglobin level
British Journal of Haematology
Ali Amid and Nick Barrowman and Isaac Odame and Melanie Kirby-Allen
DOI: 10.1111/bjh.18077
05/2022
Consensus statement for the perinatal management of patients with a thalassemia major
Blood Advances
Tippi C. MacKenzie and Ali Amid and Michael Angastiniotis and Craig Butler and Sandra Gilbert and Juan Gonzalez and Roberta L. Keller and Sandhya Kharbanda and Melanie Kirby-Allen and Barbara A. Koenig and Wade Kyono and Ashutosh Lal and Billie R. Lianoglou and Mary E. Norton and Keith K. Ogasawara and Tachjaree Panchalee and Mara Rosner and Marisa Schwab and Alexis Thompson and John S. Waye and Elliott Vichinsky
DOI: 10.1182/bloodadvances.2021005916
12/2021
Immune tolerance induction using Fc-fusion-protein recombinant factor IX in severe haemophilia B
Haemophilia
Ali Amid and Heather Perkins and Julie Gauthier and Arnaud Bonnefoy and Manuel Carcao and Georges-Étienne Rivard and Robert J. Klaassen
DOI: 10.1111/hae.14424
11/2021
Outcomes of haemoglobin Bart’s hydrops fetalis following intrauterine transfusion in Ontario, Canada
Archives of Disease in Childhood - Fetal and Neonatal Edition
Hui Jue Zhang and Ali Amid and Laura A Janzen and Catherine I Segbefia and Shiyi Chen and Uma Athale and Karen Charpentier and Manuela Merelles-Pulcini and Gareth Seaward and Edmond N Kelly and Isaac Odame and John S Waye and Greg Ryan and Melanie Kirby-Allen
DOI: 10.1136/archdischild-2019-317626
01/2021
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
The Lancet. Haematology
DOI: 10.1016/s2352-3026(20)30368-9
PubMed: 33290737
12/2020
Drisapersen associated with elevated serum factor VIII levels in Duchenne muscular dystrophy
Neurology
DOI: 10.1212/wnl.0000000000009139
03/2020
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Blood
DOI: 10.1182/blood.2019000998
PubMed: 31805182
02/2020
Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study.
The Lancet. Haematology
DOI: 10.1016/s2352-3026(18)30224-2
PubMed: 30772417
02/2019
Mild Hereditary Spherocytosis without Accompanying Hereditary Haemochromatosis: An Unrecognised Cause of Iron Overload
Acta Haematologica
Soumitra Tole and Ali Amid and Jillian Baker and Kevin Kuo and Jakob Pugi and Manuel Carcao
DOI: 10.1159/000497175
2019
Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.
Haematologica
DOI: 10.3324/haematol.2017.178368
01/2018
An international registry of survivors with Hb Bart's hydrops fetalis syndrome.
Blood
DOI: 10.1182/blood-2016-08-697110
03/2017
Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis
Blood
Ali Amid and Shiyi Chen and William Brien and Melanie Kirby-Allen and Isaac Odame
DOI: 10.1182/blood-2015-10-673889
03/2016
Hb S/ß+-thalassemia due to Hb sickle and a novel deletion of dnase I hypersensitive sites HS3 and HS4 of the ß locus control region
Haematologica
Amid, A. and Cheong, M. and Eng, B. and Hanna, M. and Hohenadel, B.-A. and Nakamura, L.M. and Walker, L. and Odame, I. and Kirby-Allen, M. and Waye, J.S.
DOI: 10.3324/haematol.2014.117408
2015
Presentation of Central Nervous System Tumours
Pediatric Neuro-Oncology
2015
Screening for thalassemia carriers in populations with a high rate of iron deficiency: Revisiting the applicability of the mentzer index and the effect of iron deficiency on Hb A2 levels
Hemoglobin
Amid, A. and Haghi-Ashtiani, B. and Kirby-Allen, M. and Haghi-Ashtiani, M.T.
DOI: 10.3109/03630269.2015.1024321
2015
Thalassaemia in children: From quality of care to quality of life
Archives of Disease in Childhood
Amid, A. and Saliba, A.N. and Taher, A.T. and Klaassen, R.J.
DOI: 10.1136/archdischild-2014-308112
2015
Improving outcomes in children with sickle cell disease: Treatment considerations and strategies
Pediatric Drugs
Amid, A. and Odame, I.
DOI: 10.1007/s40272-014-0074-4
2014
Risk factors for hyperferritinemia secondary to red blood cell transfusions in pediatric cancer patients
Pediatric Blood and Cancer
Amid, A. and Barrowman, N. and Vijenthira, A. and Lesser, P. and Mandel, K. and Ramphal, R.
DOI: 10.1002/pbc.24629
2013
Evans syndrome secondary to HIV infection
Journal of Pediatric Hematology/Oncology
Amid, A. and Leung, E.
DOI: 10.1097/MPH.0b013e3182a05a93
2013
Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma
Current Oncology
Lafay-Cousin, L. and Bouffet, E. and Hawkins, C. and Amid, A. and Huang, A. and Mabbott, D.J.
2009
Thalassemia in Iran: Epidemiology, prevention, and management
Journal of Pediatric Hematology/Oncology
Abolghasemi, H. and Amid, A. and Zeinali, S. and Radfar, M.H. and Eshghi, P. and Rahiminejad, M.S. and Ehsani, M.A. and Najmabadi, H. and Akbari, M.T. and Afrasiabi, A. and Akhavan-Niaki, H. and Hoorfar, H.
DOI: 10.1097/MPH.0b013e3180437e02
2007
International medical response to a natural disaster: Lessons learned from the bam earthquake experience
Prehospital and Disaster Medicine
Abolghasemi, H. and Radfar, M.H. and Khatami, M. and Nia, M.S. and Amid, A. and Briggs, S.M.
DOI: 10.1017/S1049023X00003599
2006
Clinical quiz
Journal of Pediatric Gastroenterology and Nutrition
Abolghasemi, H. and Kavehmanesh, Z. and Matinzadeh, Z.K. and Amid, A. and Ahmadi, M.
2005
Factor XIII deficiency in south-east Iran
Haemophilia
Eshghi, P. and Abolghasemi, H. and Sanei-Moghaddam, H. and Anwar, R. and Jazebi, M. and Amid, A. and Ala, F.A.
DOI: 10.1111/j.1365-2516.2004.00951.x
2004
An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates
Clinical Biochemistry
Abolghasemi, H. and Mehrani, H. and Amid, A.
DOI: 10.1016/j.clinbiochem.2003.11.010
2004